OSF was selected to become a member of the Gynecologic Oncology Group (GOG). Being a member site of the Gynecologic Oncology Group (GOG) is prestigious, offering access to pioneering research and clinical trials in gynecologic oncology. It provides opportunities for collaboration with leading experts in the field, enhancing professional development and knowledge exchange. Membership significantly benefits patient care by offering access to advanced and innovative treatments. It also influences the advancement of medical science and shapes clinical practice guidelines in gynecologic cancers. Additionally, GOG membership elevates an institution’s reputation, attracting top medical talent and patients seeking high-quality care.